Lv1
48 积分 2023-02-08 加入
Chronic Kidney Disease — Another Step Forward
22小时前
已完结
A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report
2个月前
已完结
Real world data on dual BLyS/APRIL inhibition with telitacicept for lupus nephritis
2个月前
已完结
Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study
2个月前
已完结
Case Report: A case of membranous nephropathy associated with primary Sjögren’s syndrome treated with telitacicept
2个月前
已完结
Telitacicept and Tacrolimus Synergy in Managing Refractory Primary Membranous Nephropathy: Case Insights
2个月前
已关闭
Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
3个月前
已完结
Minimal Change Disease
5个月前
已完结
Minimal Change Disease
5个月前
已完结
Obinutuzumab and ofatumumab are more effective than rituximab in the treatment of membranous nephropathy patients with anti-rituximab antibodies
5个月前
已完结
皖公网安备34019202002308
